Literature DB >> 26820715

Ten Years of Optimizing Outcomes for Women With Type 1 and Type 2 Diabetes in Pregnancy-The Atlantic DIP Experience.

Lisa A Owens1, Aoife M Egan1, Louise Carmody1, Fidelma Dunne1.   

Abstract

CONTEXT: Pregnancy for women with type 1 or type 2 diabetes is a time of increased risk for both mother and baby. The Atlantic Diabetes in Pregnancy program provides coordinated, evidence-based care for women with diabetes in Ireland. Founded in 2005, the program now shares outcomes over its first decade in caring for pregnant women with diabetes.
OBJECTIVE: The objective was to assess improvements in clinical outcomes after the introduction of interventions. DESIGN, SETTING, PARTICIPANTS: We retrospectively examined 445 pregnancies in women with type 1 and type 2 diabetes and compared them over two timepoints, 2005–2009 and 2010–2014. INTEVENTIONS: Interventions introduced over that time include: provision of combined antenatal/diabetes clinics, prepregnancy care, electronic data management, local clinical care guidelines, professional and patient education materials, an app, and a web site. MAIN OUTCOMES: Pregnancy outcomes were measured.
RESULTS: The introduction of the Atlantic Diabetes in Pregnancy program has been associated with a reduction in adverse neonatal outcomes. There has been a reduction in congenital malformations (5 to 1.8%; P = .04), stillbirths (2.3 vs 0.4%; P = .09), despite an upward trend in maternal age (mean age, 31.7 vs 33 years), obesity (29 vs 43%; body mass index >30 kg/m2), and excessive gestational weight gain (24 vs 38%; P = .002). These improvements in outcomes occur alongside an increase in attendance at prepregnancy care (23 to 49%; P < .001), use of folic acid (45 vs 71%; P < .001), and sustained improvement in glycemic control.
CONCLUSIONS: Changing the process of clinical care delivery and utilizing evidence-based interventions in a pragmatic clinical setting improves pregnancy outcomes for women with pregestational diabetes. We now need to target optimization of maternal body mass index before pregnancy and put a greater focus on gestational weight gain through education and monitoring.

Entities:  

Mesh:

Year:  2016        PMID: 26820715     DOI: 10.1210/jc.2015-3817

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Improving pregnancy outcomes in women with diabetes mellitus: modern management.

Authors:  Lene Ringholm; Peter Damm; Elisabeth R Mathiesen
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

2.  Risks of asphyxia-related neonatal complications in offspring of mothers with type 1 or type 2 diabetes: the impact of maternal overweight and obesity.

Authors:  Sven Cnattingius; Anna Lindam; Martina Persson
Journal:  Diabetologia       Date:  2017-04-13       Impact factor: 10.122

3.  Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.

Authors:  Oratile Kgosidialwa; Delia Bogdanet; Aoife Egan; Paula M O'Shea; Linda Biesty; Declan Devane; Fidelma Dunne
Journal:  Trials       Date:  2020-12-11       Impact factor: 2.279

4.  Gestational and pregestational diabetes in pregnant women with cystic fibrosis.

Authors:  Rachael Oxman; Andrea H Roe; Ullal Jagdeesh; Melissa S Putman
Journal:  J Clin Transl Endocrinol       Date:  2021-12-05

5.  Maternal and Fetal Outcomes in Women with Diabetes in Pregnancy Treated before and after the Introduction of a Standardized Multidisciplinary Management Protocol.

Authors:  Maddalena Morlando; Fabiana Savoia; Anna Conte; Antonio Schiattarella; Marco La Verde; Michela Petrizzo; Mauro Carpentieri; Carlo Capristo; Katherine Esposito; Nicola Colacurci
Journal:  J Diabetes Res       Date:  2021-11-12       Impact factor: 4.011

6.  Pregnancy outcomes in women with type 1 diabetes in China during 2004 to 2014: A retrospective study (the CARNATION Study).

Authors:  Sihui Luo; Xingwu Ran; Mei Zhang; Ji Hu; Daizhi Yang; Dalong Zhu; Jiajun Zhao; Xinhua Xiao; Xiaohui Guo; Tao Yang; Qin Huang; Fang Liu; Lu Jing; Jing Ma; Xinli Zhou; Fan Ping; Nan Gu; Wenwen Li; Yaling Yang; Chen Fang; Wei Bao; Xueying Zheng; Jinhua Yan; Zhiguang Zhou; Jianping Weng
Journal:  J Diabetes       Date:  2021-11-02       Impact factor: 4.530

7.  Trends in maternal characteristics and perinatal outcomes among Japanese pregnant women with type 1 and type 2 diabetes from 1982 to 2020.

Authors:  Kei Fujikawa Shingu; Masako Waguri; Mitsuyoshi Takahara; Naoto Katakami; Iichiro Shimomura
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

8.  Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes.

Authors:  Martina Persson; Sven Cnattingius; Anna-Karin Wikström; Stefan Johansson
Journal:  Diabetologia       Date:  2016-07-01       Impact factor: 10.122

9.  Pregnancy in Patients with Type One Diabetes Mellitus Treated with Continuous Subcutaneous Insulin Infusion-Preconception Basal Insulin Dose as a Potential Risk Factor for Fetal Overgrowth?

Authors:  Gloria Lekšić; Maja Baretić; Marina Ivanišević; Dubravka Jurišić-Eržen
Journal:  Int J Environ Res Public Health       Date:  2020-09-09       Impact factor: 3.390

10.  Association of Implementation of a Comprehensive Preconception-to-Pregnancy Management Plan With Pregnancy Outcomes Among Chinese Pregnant Women With Type 1 Diabetes: The CARNATION Study.

Authors:  Xueying Zheng; Daizhi Yang; Sihui Luo; Jinhua Yan; Xiaohui Guo; Huixia Yang; Wei Bao; Leif Groop; Anne Dornhorst; Jianping Weng
Journal:  Diabetes Care       Date:  2021-02-24       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.